BioClinica and Cephalon ink data management deal

By Nick Taylor

- Last updated on GMT

Related tags Data management Management Clinical trial Clinical data acquisition

BioClinica is providing Cephalon with end-to-end clinical data management services and hiring some of the biotech’s staff under a three-year, multi-million dollar deal.

Pharmas and biotechs are increasingly outsourcing substantial aspects of their businesses, leading to service providers being more like partners, and the BioClinica deal appears to follow this trend.

Under the terms of the agreement BioClinica will provide end-to-end clinical data management services to Cephalon. Specifically, this covers data management planning, clinical trial set up for electronic data capture (EDC), medical coding and training for study sites and investigators.

This is a significant expansion of the relationship between the companies, which began in 2003, and according to BioClinica marks a shift in its role from technology provider to “key services partner​”.

Employing BioClinica in this way will help Cephalon “centralise and streamline its clinical data management operations through improved process standardisation, consistency of delivery, economies of scale and cost savings​”, according to Mark Weinstein, CEO of the eClinical firm.

This is in keeping with Cephalon’s initiative to optimise operational efficiencies. The biotech is using other service partners as part of this initiative and BioClinica will work with these companies to ensure the operation runs smoothly.

To help provide these services BioClinica is hiring US-based data management staff currently employed by Cephalon. This removes the employees from Cephalon’s payroll and helps ensure BioClinica has knowledge of the biotechs operations.

EDC use

The deal also expands Cephalon’s use of BioClinica’s Express EDC. Cephalon will now use Express EDC as its default system for all clinical trials from Phase I through to Phase IV.

BioClinica designed Express EDC to be a comprehensive platform for organising the collection and dissemination of clean data. By using it BioClinica believes companies can improve the speed and quality of all aspects of the clinical trial process.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more